Literature DB >> 29909550

Methods for Measuring Risk for Type 2 Diabetes in Youth: the Oral Glucose Tolerance Test (OGTT).

Melinda E Chen1, Rebecca S Aguirre2, Tamara S Hannon3.   

Abstract

PURPOSE OF REVIEW: The oral glucose tolerance test (OGTT) is used both in clinical practice and research to assess glucose tolerance. In addition, the OGTT is utilized for surrogate measures of insulin sensitivity and the insulin response to enteral glucose and has been widely applied in the evaluation of β-cell dysfunction in obesity, prediabetes, and type 2 diabetes. Here we review the use of the OGTT and the OGTT-derived indices for measurement of risk markers for type 2 diabetes in youth. RECENT
FINDINGS: Advantages of using the OGTT for measures of diabetes risk include its accessibility and the incorporation of physiological contributions of the gut-pancreas axis in the measures of insulin response to glucose. Mathematical modeling expands the potential gains from the OGTT in physiology and clinical research. Disadvantages include individual differences in the rate of glucose absorption that modify insulin responses, imperfect control of the glycemic stimulus, and poor intraindividual reproducibility. Available research suggests the OGTT provides valuable information about the development of impaired glycemic control and β-cell function in obese youth along the spectrum of glucose tolerance.

Entities:  

Keywords:  Adolescent; Insulin sensitivity; Pediatric; Prediabetes; β-cell function

Mesh:

Substances:

Year:  2018        PMID: 29909550     DOI: 10.1007/s11892-018-1023-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  73 in total

Review 1.  The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes.

Authors:  Tamara S Hannon; Silva A Arslanian
Journal:  Ann N Y Acad Sci       Date:  2015-10-08       Impact factor: 5.691

2.  Beyond the morphology of the glucose curve following an oral glucose tolerance test in obese youth.

Authors:  Giuseppe Nolfe; Maria Rita Spreghini; Rita Wietrzycowska Sforza; Giuseppe Morino; Melania Manco
Journal:  Eur J Endocrinol       Date:  2011-10-18       Impact factor: 6.664

3.  Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals.

Authors:  Chiara Dalla Man; Marco Campioni; Kenneth S Polonsky; Rita Basu; Robert A Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

4.  ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents.

Authors:  Antoinette Moran; Kubendran Pillay; Dorothy J Becker; Carlo L Acerini
Journal:  Pediatr Diabetes       Date:  2014-09       Impact factor: 4.866

Review 5.  Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium.

Authors:  Tamara S Hannon; Steven E Kahn; Kristina M Utzschneider; Thomas A Buchanan; Kristen J Nadeau; Philip S Zeitler; David A Ehrmann; Silva A Arslanian; Sonia Caprio; Sharon L Edelstein; Peter J Savage; Kieren J Mather
Journal:  Diabetes Obes Metab       Date:  2017-06-22       Impact factor: 6.577

6.  Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth.

Authors:  Christine L Chan; Laura Pyle; Lindsey Newnes; Kristen J Nadeau; Philip S Zeitler; Megan M Kelsey
Journal:  J Clin Endocrinol Metab       Date:  2014-12-22       Impact factor: 5.958

7.  Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus.

Authors:  N M O'Meara; J Sturis; E Van Cauter; K S Polonsky
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Pattern of insulin delivery after intravenous glucose injection in man and its relation to plasma glucose disappearance.

Authors:  E Ferrannini; A Pilo
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

9.  Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-18       Impact factor: 25.391

10.  Measuring β-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice?

Authors:  Lindsey Sjaarda; SoJung Lee; Hala Tfayli; Fida Bacha; Marnie Bertolet; Silva Arslanian
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

View more
  4 in total

1.  Pitfalls of HbA1c in the Diagnosis of Diabetes.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; João Sérgio Neves; Mariana P Monteiro; Jose Luiz Medina; Brenda Dorcely; Martin Buysschaert
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

2.  Two- vs one-hour glucose tolerance testing: Predicting prediabetes in adolescent girls with obesity.

Authors:  Kannan Kasturi; Anthony U Onuzuruike; Shwetha Kunnam; Lauren B Shomaker; Jack A Yanovski; Stephanie T Chung
Journal:  Pediatr Diabetes       Date:  2018-12-27       Impact factor: 4.866

3.  Trilobatin, a Natural Food Additive, Exerts Anti-Type 2 Diabetes Effect Mediated by Nrf2/ARE and IRS-1/GLUT2 Signaling Pathways.

Authors:  Yan-Ling Shi; Yue-Ping Zhang; Huan Luo; Fan Xu; Jian-Mei Gao; Jing-Shan Shi; Qi-Hai Gong
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

4.  Shift of Glucose Peak Time During Oral Glucose Tolerance Test is Associated with Changes in Insulin Secretion and Insulin Sensitivity After Therapy with Antidiabetic Drugs in Patients with Type 2 Diabetes.

Authors:  Yanqiu Jiang; Shiwei Cui; Rongping Zhang; Xiaoqin Zhao; Lili Yao; Rong OuYang; Wei Chen; Ranran Zhou; Xuying Zhao; Zhuqi Tang; Jin Yuan; Jie Yuan; Chen Qian; Ping Huang; Yunjuan Gu; Xinlei Wang
Journal:  Diabetes Ther       Date:  2021-08-03       Impact factor: 2.945

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.